Shape points: February 21, 2008

 

 If you are having trouble viewing this e-mail, please click here

  Click here to visit our website                                                                                                                                     February 21, 2008

In this issue:

 q February's new slides in the PowerPoint Library
  

Analysis of primary prevention services for cardiovascular disease in Australia's community pharmacies

Presented by:
Joyce, A.W., Berbatis, C.G., Sunderland, V.B., & Dhaliwal, S.S.

Assesstment of Peripheral Vascualar Endothelial Function in the Ambulatory Setting

Presented by:
Jeffrey T. Kuvin, Anish Mammen, Paula Mooney, Alawi A. Alsheikh-Ali, Richard H. Karas

Interactions of wine drinking with omega-3 fatty acids in patients with coronary heart disease: a fish-like effect of moderate wine drinking 

Presented by:
Michel de Lorgeril, Patricia Salen, Jean-Louis Martin, François Boucher, and Joël de Leiris

Effect of Board Certification on Antihypertensive Treatment Intensification in Patients with Diabetes Mellitus

Presented by:

Alexander Turchin, Maria Shubina, Anna H. Chodos, Jonathan S. Einbinder, Merri L Pendergrass

Influence of a Lipid-Lowering Therapy on Calcified and Noncalcified Coronary Plaques Monitored by Multislice Detector Computed Tomography: Results of the New Age II Pilot Study

Presented by:

Burgstahler

Does Detection Of Carotid Plaque Affect Physician Behavior or Motivate Patients?

Presented by:

Rachael A. Wyman, MD; 
Giorgio Gimelli, MD, FACC; Patrick E. McBride, MD, MPH, FACC;Claudia Korcarz, DVM, RDCS;James H. Stein, MD, FACC

Influenza vaccination in secondary prevention from coronary ischemic events in coronary artery disease: Flucad study 

Presented by: 
A. Ciszewski, Z.T. Bilinska, L.B. Brydak, C.Kepka, M.Kruk, M. Romanowska,
E. Ksiezycka, J.Przyluski, W.Piotrowski, R. Maczynska,  W. Ruzyllo

Usefulness of Pravastatin in Primary Prevention of Cardiovascular Events in Women 

Presented by:
Kyoichi Mizuno, MD, PhD; Noriaki Nakaya, MD, PhD; Yasuo Ohashi, PhD; Naoko Tajima, MD, PhD; Toshio Kushiro, MD, PhD; Tamio Teramoto, MD, PhD;
Shinichiro Uchiyama, MD, PhD & Haruo Nakamura, MD, PhD;

Serum Gamma-glutamyltransferase Level and Peripheral
Arterial Disease


Presented by:

Anoop Shankar, Jialiang Li, Barbara E.K. Klein, F. Javier Nieto, Ronald Klein

Association Between Copayment and Adherence to Statin Treatment Initiated after Coronary Heart Disease Hospitalization: A Longitudinal, Retrospective, Cohort Study 

Presented by:
Xin Ye, MS, PhD, Cynthia R. Gross, PhD, Jon Schommer, PhD, Richard Cline, PhD, Wendy L. St.Peter, PharmD

Anger is associated with subclinical atherosclerosis in low SES but not in higher SES men and women. The Cardiovascular Risk in Young Finns Study 

Presented by:
Päivi Merjonen, Laura Pulkki-Råback, Sampsa Puttonen, Pertti Keskivaara, Markus Juonala, Risto Telama, Jorma Viikari, Olli T. Raitakari and Liisa Keltikangas-Järvinen

The Relationship between Age of Asthma Onset and Cardiovascular Disease in Canadians

Presented by:
Shilpa Dogra (PhD Candidate), Chris Ardern (PhD) and Joseph Baker (PhD)

Association between cardiorespiratory fitness and prevalence of carotid atherosclerosis among men with hypertension 

Presented by:
Sae Young Jae, PhD. Mercedes R Carnethon, PhD. Kevin S Heffernan, MS. Yoon-Ho Choi, MD. Moon-Kyu Lee, MD. Bo Fernhall, PhD

Cardiorespiratory Fitness and Adiposity as Mortality Predictors in Older Adults

Presented by:

Xuemei Sui, Michael J. LaMonte, James N. Laditka, James W. Hardin, Nancy Chase, Steven P. Hooker & Steven N. Blair

Predicted risk of coronary heart disease among persons with type 2 diabetes.

Presented by:

Kirk JK, Bertoni AG, Case D,
Bell RA, Goff DC Jr, Narayan KM.

Exercise Capacity and Mortality in Black and White Men

Presented by:
Kokkinos P

Serum Cystatin C Predicts Progression of Subclinical Coronary Atherosclerosis in Persons with Type 1 Diabetes 

Presented by:
David Maahs,
Lorraine Ogden, Greg Kinney, Janet Snell-Bergeon, Adam Kretowski, Marian Rewers

Diabetic Retinopathy and Increased Incidence of Cardiovascular Events in Type 2 Diabetic Patients Presented by:
G. Targher, L. Bertolini, L. Zenari, G. Lippi,
I. Pichiri, G. Zoppini, M. Muggeo, G. Arcaro

Double-edged relationship between adiposity and coronary artery calcification in Type 1 Diabetes

Presented by:
Baqiyyah Conway, MA MPH, Rachel Miller, MS, Tina Costacou, PhD, Linda Fried, MD, Sheryl Kelsey, PhD Rohbert Evans, PhD, Daniel Edmundowicz, MD, Trevor Orchard, MD

Phosphorus Levels are Associated with Subclinical Atherosclerosis in the General Population

Presented by:

S J Onufrak, MPH, A Bellasi, MD,  F Cardarelli, MD, L J Shaw, PhD,C A Herzog, MD, V Vaccarino, MD, and P Raggi, MD.

à 20 new PPT files with
    up-to-date research
    uploaded in our SHAPE 
    Points library

Featured Links:

·    SHAPE Guideline
·    Downloads
·    PowerPoint Library

·    Newsletter Archive

Chairman
Morteza Naghavi, M.D

Board of Directors
Arthur Agatston, M.D.
Daniel Berman, M.D.
Matthew Budoff, M.D.
Erling Falk, MD, Ph.D.
Craig Hartley, Ph.D.
Harvey Hecht, M.D.
Roxana Mehran, M.D.
Ralph Metcalfe, Ph.D.
Joycelyn Ray, JD.
P.K. Shah, M.D.
Leslee Shaw, Ph.D.
JoAnne Zawitoski, Esq.

Board of Advisors
Juhani Airaksinen, M.D.
Dan E. Arking, M.D.
Juan Badimon, Ph.D
Roger Blumenthal, M.D.
Max A. Cameau, C.A.P.
Jay N. Cohn, M.D.
Ioannis Kakadiaris, Ph.D.
Sanjay Kaul, M.D.
Dan Keeney, A.P.R.
Wolfgang Koenig, MD, Ph.D.
Daniel Lane, MD, Ph.D.
Tasneem Z. Naqvi, M.D.

Director of Scientific Publications
Khurram Nasir, M.D.

Director of Public Relations
Paul Galloway

Director of Fundraising
Barbara S. Loggins

Mission:

To eradicate heart attack by championing new strategies for prevention while advancing the scientific quest for a cure.

 
 
 
 
 
 
 
 
 
 
 
 
 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 


  



MULTIMEDIA FEATURES 
Quiz & Poll 
Patient's Question

Which condition is more dangerous? (better predicts a near future heart attack)
High blood cholesterol
High coronary calcium

Doctor's Question

Would you treat individuals with normal cholesterol but high coronary calcium or carotid IMT? (What is this?)
No                            
Yes                            
SEARCH: